Whilst Rybelsus (semaglutide) does not cause dangerous withdrawal symptoms, stopping this type 2 diabetes medication suddenly without medical supervision is not recommended
Ready to ditch dull skin for good
Peak weight loss on GLP-1 medications usually hits around the one-year mark, so this means most patients need to think in terms of 18 months or so from starting therapy to being ready for cosmetic facial work
By the time women come to see me in their 30s and 40s, extensions are the only thing theyve ever done with their hair, she says
Backed by clinical use: Rybelsus is backed by numerous clinical trials that have again and again established its capabilities in weight reduction
As of early 2025, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had received hundreds of reports of acute pancreatitis linked to GLP-1 drugs, including Ozempic and Wegovy